Estelle Guiard Selected Research

Neoplasm Metastasis (Metastasis)

12/2019

Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Estelle Guiard Research Topics

Disease

3	Neoplasms (Cancer) 01/2024 - 10/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2024 - 11/2021
2	Prostatic Neoplasms (Prostate Cancer) 10/2020 - 12/2019
1	Multiple Sclerosis 12/2023
1	Stroke (Strokes) 11/2021
1	Myocardial Infarction 11/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021
1	Pain (Aches) 10/2020
1	Neoplasm Metastasis (Metastasis) 12/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Ulcer 03/2010

Drug/Important Bio-Agent (IBA)

2	cabazitaxel FDA Link 10/2020 - 12/2019
1	Immunologic Factors (Immunomodulators)IBA 12/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021
1	TicagrelorIBA 11/2021
1	Docetaxel (Taxotere)FDA Link 12/2019
1	BismuthIBA 01/2019
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2010

Therapy/Procedure

2	Castration 10/2020 - 12/2019
1	Transplantation 01/2024
1	Therapeutics 10/2020
1	Polypharmacy 12/2019